UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION
UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934
OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934.
Commission File Number 001-39633
Abcam Limited
(Exact name of registrant as specified in its charter)
Discovery Drive
Cambridge Biomedical Campus
Cambridge, CB2 0AX
United Kingdom
Tel: +44 (0) 1223 696000
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
Ordinary Shares, nominal value £0.002 per share*
American Depositary Shares, each representing one (1) Ordinary Share
(Title of each class of securities covered by this Form)
| * | Not for trading, but only in connection with the listing on the Nasdaq Global Select Market of the American depositary shares |
None
(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
Rule 12g-4(a)(1) | ☒ | |
Rule 12g-4(a)(2) | ☐ | |
Rule 12h-3(b)(1)(i) | ☒ | |
Rule 12h-3(b)(1)(ii) | ☐ | |
Rule 15d-6 | ☐ | |
Rule 15d-22(b) | ☐ |
Approximate number of holders of record as of the certification or notice date: two
Pursuant to the requirements of the Securities Exchange Act of 1934, Abcam Limited has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.
| ABCAM LIMITED | ||||||
| Date: | December 18, 2023 | By: | /s/ Alan Hirzel | |||
| Name: | Alan Hirzel | |||||
| Title: | Chief Executive Officer | |||||
